SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverABT
HealthcareNYSEUSD

Abbott Laboratories

$0012345678900123456789.0012345678900123456789+9.1%
52w low (est.) $80.02$123.57 52w high (est.)
Peers
Market data
Market cap
$163.61B
52-week range
$81.97 – $137.49
Beta (vs market)
0.61
Sector
Healthcare
Valuation
P/E ratio
26.3x
DCF fair value
$37.57
Margin of safety
-62.0%
Forward P/E
15.5x
PEG ratio
1.41
Dividend yield
2.67%
Quality & efficiency
Moat score
69/100
Return on equity
12.3%
Profit margin
13.9%
Debt / equity
0.65
Growth & analysts
Revenue growth (YoY)
+7.8%
Analyst target
$116.40
Target upside
+17.8%
Analysts covering
25

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Valuation

ValueGrowthProfitHealthIncome41QUALITY
Overall Rating
46
Hold
Hold
Moat Score69
DCF Intrinsic Value
$37.57-62.0% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$163.61B
P/E Ratio
26.3
Dividend Yield
2.67%
Revenue Growth
+7.8%
Profit Margin
13.9%
ROE
12.3%
Debt / Equity
0.65
Beta
0.61
Dividend Aristocrats
vs Healthcare sector:P/E 26 vs 28 · cheaperMoat 69 vs 7Yield 2.67% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · ABT